Skip to main content

Table 1 Distribution of background factors in postmenopausal women diagnosed with breast cancer in relation to age at menarche

From: The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer

 

Age at menarche, years

P valuea

 

≤ 11

> 11 and ≤13

> 13 and ≤14

> 14

 
 

Column frequency, number (percentage)

 

Total number of cases (n = 2,640)

167

989

698

542

 

Background factors

     

Menstrual cycle length, days

     

   ≤27.5

35 (30)

183 (26)

125 (26)

93 (26)

 

   28

64 (55)

392 (55)

258 (54)

191 (54)

 

   > 28

17 (15)

136 (19)

96 (20)

71 (20)

0.877

Irregular menstruation

     

   No

159 (96)

39 (4)

18 (3)

518 (98)

 

   Yes

7 (4)

940 (96)

672 (97)

13 (2)

0.246

Age at first birth, years

     

   < 25

73 (51)

418 (50)

268 (45)

226 (49)

 

   ≥25 and < 30

44 (31)

281 (34)

200 (34)

149 (32)

 

   ≥30

27 (19)

136 (16)

129 (21)

86 (19)

0.240

Parity

     

   0

23 (14)

154 (16)

101 (14)

81 (15)

 

   1

30 (18)

215 (21)

154 (22)

105 (19)

 

   2

68 (41)

362 (37)

269 (39)

215 (40)

 

   3+

46 (28)

258 (26)

174 (25)

141 (26)

0.893

Pregnancy terminated < 6 months, nulliparous

     

   No

7 (88)

15 (38)

18 (49)

9 (45)

 

   Yes

1 (12)

25 (62)

19 (51)

11 (55)

0.079

Pregnancy terminated < 6 months, parous

     

   No

100 (71)

631 (76)

431 (73)

363 (79)

 

   Yes

40 (29)

197 (24)

160 (27)

95 (21)

0.069

Age at menopause, yearsb

     

   < 50

45 (31)

261 (31)

198 (34)

133 (28)

 

   50–55

86 (59)

520 (62)

344 (58)

299 (63)

 

   > 55

14 (10)

55 (7)

47 (8)

43 (9)

0.312

Ever use of MHTc

     

   No

105 (63)

646 (66)

483 (69)

370 (68)

 

   Yes

61 (37)

340 (34)

215 (31)

171 (32)

0.258

MHT use by general type

     

   Exclusive estrogen use

14 (9)

67 (7)

54 (8)

39 (8)

 

   Estrogen-progestin combined use

39 (25)

233 (25)

142 (21)

111 (21)

0.566

Diagnosed via mammographic screening

     

   Screening

102 (61)

546 (56)

399 (58)

301 (57)

 

   Other

64 (39)

436 (44)

288 (42)

228 (43)

0.484

Deceased at end of 5-year follow-up

27 (16)

134 (14)

101 (15)

74 (14)

0.802

Breast cancer deaths at end of 5-year follow-up (total = 264)

23 (14)

89 (9)

71 (10)

46 (8)

0.186

  1. aPearson chi-square tests of association between groups. bAmong women with a natural known menopause. cMenopausal hormone therapy includes all treatments: exclusive estrogens, exclusive progestins, and combined estrogen-progestin therapy.